Cell membrane-encapsulated nanoparticles for vaccines and immunotherapy_中国颗粒学会

在线阅读

Volurnes 72-75 (2023)

Volurnes 60-71 (2022)

Volurnes 54-59 (2021)

Volurnes 48-53 (2020)

Volurnes 42-47 (2019)

Volurnes 36-41 (2018)

Volurnes 30-35 (2017)

Volurnes 24-29 (2016)

Volurnes 18-23 (2015)

Volurnes 12-17 (2014)

Volurne 11 (2013)

Volurne 10 (2012)

Volurne 9 (2011)

Volurne 8 (2010)

Volurne 7 (2009)

Volurne 6 (2008)

Volurne 5 (2007)

Volurne 4 (2006)

Volurne 3 (2005)

Volurne 2 (2004)

Volurne 1 (2003)

在线阅读

Partic. vol. 64 pp. 35-42 (May 2022)
doi: 10.1016/j.partic.2021.04.017

Cell membrane-encapsulated nanoparticles for vaccines and immunotherapy

Wei Xianga,1, Xue Liub,1, Lili Zhanga, Chao Liua,c,*, Gang Liua,*

Show more

liuchao66888@163.com gangliu.cmitm@xmu.edu.cn

Highlights

    • Cell membrane coating technologies bestow nanocarriers with natural capability. • A variety of cell types can be used as sources of membranes to load nanoparticles. • Diversity of cell membranes and nanocarriers enables extensive applicability. • Cell membrane-coated nanoparticles will achieve promotion in clinical application.

Abstract

Functionalized nanoparticles are widely used in drug targeted delivery and immune microenvironment regulation. As a new type of biomaterial, cell-derived carriers are receiving considerable attention in clinical translation owing to their desirable biocompatibility and lower toxicity. Importantly, cell membrane-encapsulated nanoparticles can achieve specific biological effects from the benefit of their parent cell characteristics. In this review, we introduce the cell membrane coating technologies that are under extensive investigation, we also summarize various applications that have been developed for immunotherapy, and discuss the prospects in this field. With further understanding and integration with advanced biotechnology methods, it is believed that the continuing development of cell membrane-encapsulated nanoparticles will achieve promotion in clinical application.

Graphical abstract

Keywords

Cell membrane; Nanoparticle; Vaccine; Immunotherapy